Detalhe da pesquisa
1.
Spotlight on the real-world treatment of CML pts in Germany: a retrospective survey in private oncology practices.
Ann Hematol
; 103(5): 1569-1575, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38472361
2.
Steady-state versus chemotherapy-based hematopoietic cell mobilization after anti-CD38-based induction therapy in newly diagnosed multiple myeloma.
Transfusion
; 63(11): 2131-2139, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850414
3.
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
Ann Hematol
; 102(10): 2741-2752, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592092
4.
Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia.
Acta Haematol
; : 1-8, 2023 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37848002
5.
Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39).
Transfusion
; 62(1): 157-164, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893987
6.
Analysis of stem cell collections in adult patients with Ewing sarcoma.
Transfusion
; 62(8): 1612-1618, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35801531
7.
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
Haematologica
; 106(6): 1599-1607, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32499241
8.
Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantation.
Am J Hematol
; 96(10): 1287-1294, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289154
9.
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
Acta Haematol
; 143(3): 217-231, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31590170
10.
Concomitant and noncanonical JAK2 and MPL mutations in JAK2V617F- and MPLW515 L-positive myelofibrosis.
Genes Chromosomes Cancer
; 58(11): 747-755, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31135094
11.
Pretreatment CD34+/CD38- Cell Burden as Prognostic Factor in Myelodysplastic Syndrome Patients Receiving Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1560-1566, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30928626
12.
Comparison of non-myeloablative and reduced-intensity allogeneic stem cell transplantation in older patients with myelodysplastic syndromes.
Am J Hematol
; 94(12): 1344-1352, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495933
13.
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.
Ann Hematol
; 97(10): 1757-1765, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785446
14.
Outcome prediction by the knowledge bank approach in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation.
Am J Hematol
; 97(10): E382-E384, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802783
15.
Prognostic impact of the CD34+/CD38- cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation.
Am J Hematol
; 92(4): 388-396, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28133783
16.
[Liver stiffness in allogeneic stem cell transplantation]. / Bedeutung der Lebersteifigkeitsmessung für Risikoprädiktion und Komplikationsmanagement bei allogener Stammzelltransplantation.
Z Gastroenterol
; 59(9): 995-996, 2021 09.
Artigo
em Alemão
| MEDLINE | ID: mdl-34507378
17.
High expression of the stem cell marker GPR56 at diagnosis identifies acute myeloid leukemia patients at higher relapse risk after allogeneic stem cell transplantation in context with the CD34+/CD38- population.
Haematologica
; 105(10): e507, 2020 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054093
18.
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC).
Bone Marrow Transplant
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664589
19.
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.
Leukemia
; 38(2): 372-382, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184754
20.
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma.
Nat Cancer
; 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641734